Product Information
ESTRADIOL 0.075 MG PATCH(2/WK) is a generic product labeled by Noven Therapeutics, LLC, priced at $8.1128 per EA under NDC 68968347508. Its NADAC has been published 407 times since Dec 19, 2018.
FDA first approved this application on Oct 29, 2012. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.075 mg/d
Manufacturer
Noven Therapeutics, LLCNDC
68968347508
Classification
Generic
Dosage Form
FILM, EXTENDED RELEASE
Route
TRANSDERMAL
Effective Date
9/23/2026
Active Ingredients
ESTRADIOLApproval Type
Authorized Generic (NDA)
FDA Application
NDA203752FDA Approved
10/29/2012
TE Code
AB3
On Market Since
1/1/2018
Pharmacological Classes
Price Statistics
The NADAC for ESTRADIOL 0.075 MG PATCH(2/WK) has been published 407 times since Dec 19, 2018, and over the history we have for it it has risen 3.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.1128 per EA |
|---|---|
| All-time high | $9.3768 (Mar 10, 2021) |
| All-time low | $5.2541 (May 22, 2024) |
| 52-week high | $8.1128 |
| 52-week low | $6.8560 |
| Median price | $7.2363 |
| Average price | $7.2836 |
| Largest weekly change | +31.0% (Jun 19, 2024) |
| Weeks tracked | 407 |
| Tracking since | Dec 19, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Noven Therapeutics, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ESTRADIOL 0.075 MG PATCH(2/WK)?
The current National Average Drug Acquisition Cost (NADAC) for ESTRADIOL 0.075 MG PATCH(2/WK), manufactured by Noven Therapeutics, LLC, is $8.1128 per EA (NDC 68968347508), effective Sep 30, 2026.
How has the price of ESTRADIOL 0.075 MG PATCH(2/WK) changed over time?
Over the history we have for it, the NADAC for ESTRADIOL 0.075 MG PATCH(2/WK) has risen 3.1%. It has been tracked across 407 weekly CMS publications since Dec 19, 2018.
What are the highest and lowest recorded NADAC prices for ESTRADIOL 0.075 MG PATCH(2/WK)?
Since Dec 19, 2018, the NADAC for ESTRADIOL 0.075 MG PATCH(2/WK) has ranged from a low of $5.2541 (May 22, 2024) to a high of $9.3768 (Mar 10, 2021), with a median of $7.2363 per EA.
Are there cheaper alternatives to ESTRADIOL 0.075 MG PATCH(2/WK)?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ESTRADIOL 0.075 MG PATCH(2/WK) in a comparable dosage form, but none are currently priced below it.
Who manufactures ESTRADIOL 0.075 MG PATCH(2/WK)?
ESTRADIOL 0.075 MG PATCH(2/WK) (NDC 68968347508) is labeled by Noven Therapeutics, LLC, and CMS classifies it as a generic product.